It’s 100% happens and we were not limited in what we could buy. Or when we could buy. Certain people at the company were and they were several times because I was involved with pricing and contracting that we were under a hold and we’re not allowed to buy or sell shares of our own company And I suppose we would be encouraged not to do the same with competitive companies, but if I wanted to buy something like Visa or Apple that wasn’t involved in biotech, then I was free to do so. Those holes were usually 1/4 at a time and those announcements came out of nowhere. Let’s say I wanted to sell stock next week because I’m buying a house and all of a sudden one afternoon you’re on a conference call and they tell you you’re under a hold for the next three months and you cannot buy or sell the company stock. It was quite scary for some because you were literally handcuffed.
But back to your question, yes if there was something that was learned at a conference about another company you certainly could purchase or sell stock because what you’re learning at the conference is public information. We only traded based on public information. I only bought stock in the companies. I worked for through employee stock, purchase plans, and stock option awards. I never purchased on the open market through brokerage account accounts. Those were used for other biotech companies.
Great question and great point. There will be a lot of talk at ESMO amongst people in the industry and people in the scientific community and medical community and they will be telling their colleagues. It’s kindling right now. The brushfire will start.